29 Elevated Flt3L predicts long-term survival in patients with high-grade gastroenteropancreatic neuroendocrine neoplasms

• Bertram Wiedenmann,
• Tom Luedde,
• Frank Tacke,
• Linda Hammerich,
• Christoph Roderburg,
• Katharina Detjen,
• Raik Otto,
• Yvonne Giesecke,
• Lukas Geisler,
• Pamela Riemer,
• Henning Jann,
• Carsten Grötzinger,
• Christine Sers,
• Ulf Leser,
• Michael Sigal

Affiliations

Bertram Wiedenmann

1Department of Gastroenterology and Hepatology, Charité University Medicine, Berlin, Germany

Tom Luedde

Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf, Düsseldorf, Germany

Frank Tacke

Department of Gastroenterology and Hepatology, Charité Universitätsmedizin Berlin, Berlin, Germany

Linda Hammerich

Aff1 grid.59734.3c0000000106702351Icahn School of Medicine at Mount Sinai New York NY USA

Christoph Roderburg

Clinic for Gastroenterology, Hepatology and Infectious Diseases, University Hospital Düsseldorf, Medical Faculty of Heinrich Heine University Düsseldorf, Düsseldorf, Germany

Katharina Detjen

1Charité Universitätsmedizin Berlin, Berlin, Germany

Raik Otto

2Humboldt-Universität zu Berlin, Berlin, Germany

Yvonne Giesecke

1Charité Universitätsmedizin Berlin, Berlin, Germany

Lukas Geisler

1Charité Universitätsmedizin Berlin, Berlin, Germany

Pamela Riemer

1Charité Universitätsmedizin Berlin, Berlin, Germany

Henning Jann

1Charité Universitätsmedizin Berlin, Berlin, Germany

Carsten Grötzinger

1Charité Universitätsmedizin Berlin, Berlin, Germany

Christine Sers

1Charité Universitätsmedizin Berlin, Berlin, Germany

Ulf Leser

2Humboldt-Universität zu Berlin, Berlin, Germany

Michael Sigal

1Charité Universitätsmedizin Berlin, Berlin, Germany